Source link : https://www.newshealth.biz/health-news/esr1-driven-resistance-to-cdk4-6-inhibitors-in-breast-cancer-thwarted-by-serds/
Mutations in ESR1 do not appear to confer breast cancer resistance to cyclin-dependent kinase (CDK)4/6 inhibitors, an analysis of clinical practice data suggested. Patients with metastatic hormone receptor-positive breast cancer had a similar time to next treatment with CDK4/6 inhibition regardless of ESR1 mutation status. Stratification by concurrent endocrine partner showed that patients with ESR1 […]
Author : News Health
Publish date : 2024-04-25 21:01:04
Copyright for syndicated content belongs to the linked Source.